City

Baltimore (1)

Berlin (1)

Frankfurt am main (1)

Moscow (1)

Tuebingen (1)

Condition

Immune Deficiency Disease (3)

Bone Marrow Failure (1)

Bone Marrow Failure Syndromes (1)

Graft vs Host Disease (1)

Leukemia, Myeloid, Acute (1)

Opportunistic Infections (1)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Primary Immune Deficiency Disorder (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Phase

phase 1/phase 2 (2)

phase 2 (1)

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

University Hospital Tuebingen (1)

Collaborator

Intervention

alemtuzumab (1)

cd45ra-depleted peripheral blood mononuclear cells (1)

covac-1 (1)

cyclophosphamide (1)

fludarabine (1)

low dose total body irradiation (1)

melphalan (1)

mycophenolate mofetil (1)

tacrolimus (1)

Study Documents

Intervention Type

biological (2)

drug (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

immune deficiency disease

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting

Primary Immune Deficiency Disorder
+2 more

Alemtuzumab
+6 more

Baltimore, Maryland

Johns Hopkins University

Oct 20, 2022

Immune Deficiency Disease Trial in Tuebingen, Frankfurt am main, Berlin (CoVAC-1)

Active, not recruiting

Immune Deficiency Disease

CoVAC-1

Tuebingen, Baden-Wuerttemberg, Germany
+2 more

Jan 14, 2022

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Immune Deficiency Disease Trial in Moscow

Completed

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
+5 more

CD45RA-depleted peripheral blood mononuclear cells

Moscow, Russian Federation

Federal Research Center for pediatric hematology, oncology and i

Apr 21, 2016